These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26586838)

  • 21. Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study.
    Webb SM; Badia X; Surinach NL;
    Eur J Endocrinol; 2006 Aug; 155(2):269-77. PubMed ID: 16868140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GH deficiency in patients after cure of acromegaly by surgery alone.
    Yamada S; Fukuhara N; Nishioka H; Takeshita A; Suzuki H; Miyakawa M; Takeuchi Y
    Eur J Endocrinol; 2011 Dec; 165(6):873-9. PubMed ID: 21964960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly.
    Espinosa-de-los-Monteros AL; Mercado M; Sosa E; Lizama O; Guinto G; Lopez-Felix B; Garcia O; Hernández I; Ovalle A; Mendoza V
    J Neurosurg; 2002 Aug; 97(2):287-92. PubMed ID: 12186455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients with acromegaly might not be at higher risk for dopamine agonist-induced impulse control disorders than those with prolactinomas.
    Ozkaya HM; Sahin S; Korkmaz OP; Durcan E; Sahin HR; Celik E; Poyraz BC; Kadioglu P
    Growth Horm IGF Res; 2020 Dec; 55():101356. PubMed ID: 33010581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission.
    Pollock BE; Jacob JT; Brown PD; Nippoldt TB
    J Neurosurg; 2007 May; 106(5):833-8. PubMed ID: 17542527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.
    Nishioka H; Fukuhara N; Horiguchi K; Yamada S
    J Neurosurg; 2014 Sep; 121(3):505-10. PubMed ID: 25014437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone-secreting adenomas: pathology and cell biology.
    Lopes MB
    Neurosurg Focus; 2010 Oct; 29(4):E2. PubMed ID: 20887127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas.
    Minniti G; Jaffrain-Rea ML; Osti M; Esposito V; Santoro A; Solda F; Gargiulo P; Tamburrano G; Enrici RM
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):210-6. PubMed ID: 15670198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.
    Bevan JS; Atkin SL; Atkinson AB; Bouloux PM; Hanna F; Harris PE; James RA; McConnell M; Roberts GA; Scanlon MF; Stewart PM; Teasdale E; Turner HE; Wass JA; Wardlaw JM
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4554-63. PubMed ID: 12364434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reliability of the oral glucose tolerance test in the early postoperative assessment of acromegaly remission.
    Kristof RA; Neuloh G; Redel L; Klingmüller D; Schramm J
    J Neurosurg; 2002 Dec; 97(6):1282-6. PubMed ID: 12507124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Personality in patients with pituitary adenomas is characterized by increased anxiety-related traits: comparison of 70 acromegalic patients with patients with non-functioning pituitary adenomas and age- and gender-matched controls.
    Sievers C; Ising M; Pfister H; Dimopoulou C; Schneider HJ; Roemmler J; Schopohl J; Stalla GK
    Eur J Endocrinol; 2009 Mar; 160(3):367-73. PubMed ID: 19073833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent negative illness perceptions despite long-term biochemical control of acromegaly: novel application of the drawing test.
    Tiemensma J; Pereira AM; Romijn JA; Broadbent E; Biermasz NR; Kaptein AA
    Eur J Endocrinol; 2015 May; 172(5):583-93. PubMed ID: 25724922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency.
    Giavoli C; Profka E; Verrua E; Ronchi CL; Ferrante E; Bergamaschi S; Sala E; Malchiodi E; Lania AG; Arosio M; Ambrosi B; Spada A; Beck-Peccoz P
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3983-8. PubMed ID: 22904173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GH deficiency in patients irradiated for acromegaly: significance of GH stimulatory tests in relation to the 24 h GH secretion.
    van der Klaauw AA; Pereira AM; van Thiel SW; Smit JW; Corssmit EP; Biermasz NR; Frolich M; Iranmanesh A; Veldhuis JD; Roelfsema F; Romijn JA
    Eur J Endocrinol; 2006 Jun; 154(6):851-8. PubMed ID: 16728545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments.
    Ronchi CL; Giavoli C; Ferrante E; Verrua E; Bergamaschi S; Ferrari DI; Corbetta S; Montefusco L; Arosio M; Ambrosi B; Spada A; Beck-Peccoz P
    Eur J Endocrinol; 2009 Jul; 161(1):37-42. PubMed ID: 19351744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acromegaly surgery in Manchester revisited--the impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission.
    Wang YY; Higham C; Kearney T; Davis JR; Trainer P; Gnanalingham KK
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):399-406. PubMed ID: 21824170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly.
    Carmichael JD; Bonert VS; Mirocha JM; Melmed S
    J Clin Endocrinol Metab; 2009 Feb; 94(2):523-7. PubMed ID: 19033371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The common consensus criteria have high predictive values for long-term postoperative acromegaly remission.
    Kristof RA; Grote A; Redel L; Neuloh G; Klingmüller D; Schramm J
    Acta Neurochir (Wien); 2011 Jan; 153(1):19-25. PubMed ID: 20845050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire.
    Vandeva S; Yaneva M; Natchev E; Elenkova A; Kalinov K; Zacharieva S
    Endocrine; 2015 Aug; 49(3):774-82. PubMed ID: 25561370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.